Cargando…
Inhibition of Hedgehog-dependent tumors and cancer stem cells by a newly identified naturally occurring chemotype
Hedgehog (Hh) inhibitors have emerged as valid tools in the treatment of a wide range of cancers. Indeed, aberrant activation of the Hh pathway occurring either by ligand-dependent or -independent mechanisms is a key driver in tumorigenesis. The smoothened (Smo) receptor is one of the main upstream...
Autores principales: | Infante, Paola, Alfonsi, Romina, Ingallina, Cinzia, Quaglio, Deborah, Ghirga, Francesca, D'Acquarica, Ilaria, Bernardi, Flavia, Di Magno, Laura, Canettieri, Gianluca, Screpanti, Isabella, Gulino, Alberto, Botta, Bruno, Mori, Mattia, Di Marcotullio, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059851/ https://www.ncbi.nlm.nih.gov/pubmed/27899820 http://dx.doi.org/10.1038/cddis.2016.195 |
Ejemplares similares
-
Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
por: Calcaterra, Andrea, et al.
Publicado: (2018) -
Gli1/DNA interaction is a druggable target for Hedgehog-dependent tumors
por: Infante, Paola, et al.
Publicado: (2015) -
Gli2 Acetylation at Lysine 757 Regulates Hedgehog-Dependent Transcriptional Output by Preventing Its Promoter Occupancy
por: Coni, Sonia, et al.
Publicado: (2013) -
Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis
por: Infante, Paola, et al.
Publicado: (2018) -
A Smo/Gli Multitarget Hedgehog Pathway Inhibitor Impairs Tumor Growth
por: Lospinoso Severini, Ludovica, et al.
Publicado: (2019)